NOXOPHARM
Noxopharm is an Australian publicly-listed (ASX: NOX) clinical stage drug development company. The clinical stage drug candidate is Veyonda® (previously known as NOX-66). Veyonda® is a first-in-class, dual-acting cytotoxic and immuno-oncology drug candidate designed to enhance the effectiveness and safety of both chemotherapy and radiotherapy. At one level, Veyonda® enhances the cancer-killing effect of standard chemotherapy and radiotherapy, thereby enabling lower doses of these toxic therapies to be used.
NOXOPHARM
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2015-01-01
Address:
Turramurra, New South Wales, Australia
Country:
Australia
Website Url:
http://www.noxopharm.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
49 M AUD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager Google Universal Analytics Font Awesome Global Site Tag
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Current Employees Featured
Founder
Stock Details
Investors List
The Lind Partners
The Lind Partners investment in Post-IPO Debt - Noxopharm
Official Site Inspections
http://www.noxopharm.com Semrush global rank: 4.51 M Semrush visits lastest month: 2.37 K
- Host name: a290d26420470737c.awsglobalaccelerator.com
- IP address: 15.197.133.181
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Noxopharm"
About Us | Noxopharm
About Noxopharm Noxopharm Limited (ASX:NOX) is a clinical-stage Australian biotech company discovering and developing novel treatments for cancer and inflammation, including a …See details»
Noxopharm Limited (NOX.AX) - Yahoo Finance
See the company profile for Noxopharm Limited (NOX.AX) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Noxopharm Limited | LinkedIn
Noxopharm Limited (ASX:NOX) is a clinical-stage Australian biotech company discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to …See details»
Noxopharm (ASX:NOX) Company Profile & Description
6 days ago Company profile for Noxopharm Limited (ASX:NOX) with a description, list of executives, contact details and other key facts.See details»
Noxopharm Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Jun 21, 2025 Explore Noxopharm Ltd. with its drug pipeline, therapeutic area, technology platform, 7 clinical trials, 7 news, and 4 literature, Disease Domain:Neoplasms, Nervous ...See details»
Noxopharm Limited: Shareholders Board Members Managers and …
Jul 9, 2025 Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to …See details»
NOXOPHARM LIMITED Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for NOXOPHARM LIMITED of GLENHAVEN, NEW SOUTH WALES. Get the latest business insights from Dun & …See details»
NOX News, Analysis, Announcements & Results | Noxopharm …
2 days ago The latest Noxopharm Limited [NOX] news, articles, data and analysis from The Australian Financial ReviewSee details»
Noxopharm - Funding, Financials, Valuation & Investors
Noxopharm is an Australian publicly-listed (ASX: NOX) clinical stage drug development company.See details»
Noxopharm - Products, Competitors, Financials, Employees, …
Noxopharm is a biotech company focused on discovering and developing novel treatments for cancer and inflammation, as well as enhancing mRNA vaccines. Use the CB Insights Platform …See details»
Noxopharm
Noxopharm Limited (ASX:NOX) is a clinical-stage Australian biotech company discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to improve the safety …See details»
Noxopharm Ltd, NOX:ASX profile - FT.com - Financial Times
Apr 10, 2025 Noxopharm Ltd (NOX:ASX) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.See details»
Noxopharm Company Profile - Office Locations, Competitors
See insights on Noxopharm including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
About Noxopharm | Pharmorage
About Noxopharm Noxopharm Limited (ASX:NOX) is an innovative Australian biotech company discovering and developing novel treatments for cancer and inflammation, including a …See details»
Noxopharm Annual Report Year Ended 30 June 2022
Sydney, 26 September 2022: Innovative biotech company Noxopharm Limited (ASX:NOX) is pleased to release its Annual Report for the 12 months ended 30 June 2022.See details»
Noxopharm Limited (NOXOF) Company Profile & Facts - Yahoo …
See the company profile for Noxopharm Limited (NOXOF) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Noxopharm - News & Analysis - Crunchbase
Oct 12, 2023 Noxopharm is an Australian publicly-listed (ASX: NOX) clinical stage drug development company.See details»
Noxopharm Ltd. (Noxopharm Ltd.) - 药物管线_专利_临床试验_投融 …
Jun 21, 2025 了解Noxopharm Ltd. (Noxopharm Ltd.)公司的药物管线，治疗领域，技术平台，以及它的7项临床试验, 7篇新闻和4篇文献，疾病领域:肿瘤，神经系统疾病，内分泌与代谢疾 …See details»
Getting to know Noxopharm and their approach to human …
News for pharmacy prosGetting to know Noxopharm and their approach to human degenerative disease Thought Leader: Dr. Graham Kelly, CEO and Managing Director, Noxopharm In this …See details»
Noxopharm - Profiles & Contacts - Crunchbase
Noxopharm is an Australian publicly-listed (ASX: NOX) clinical stage drug development company.See details»